Search results
Results From The WOW.Com Content Network
Novartis and Viatris were hit with a federal lawsuit in Maryland on Monday by the family of a woman whose tissue cells were taken from her body in the 1950s and used to fuel medical research and ...
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [ 4][ 5] Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to ...
On April 16, 2024, Take-Two Interactive announced plans to lay off 5% of its workforce and cancel several video game projects. The company cited a cost-reduction plan, anticipating total charges of $160 million to $200 million. These measures are expected to be largely implemented by December 31, 2024. [ 128]
Loaded 0%. Corporate America can't seem to lay off workers fast enough. U.S. employers have already axed north of 100,000 jobs this year according to the latest figures from data firm Challenger ...
trellix.com. Trellix(formerly FireEyeand McAfee Enterprise) is a privately held cybersecuritycompany that was founded in 2022. It has been involved in the detection and prevention of major cybersecurity attacks. It provides hardware, software, and services to investigate cybersecurity attacks, protect against malicious software, and analyze IT ...
Thursday's layoff announcement highlighted these efforts. "We love the creative engine of this company. But obviously, a big chunk of the company is in the linear world, and we know linear is ...
Electronic Arts is laying off 5% of its workforce, making it the latest video game company to enact staffing reductions in the first quarter of the year. In its most recent annual SEC filing ...
Mr. Justice Aftab Alam [ 1] Novartis v. Union of India & Others is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent Gleevec in India, and was the culmination of a seven-year-long litigation fought by Novartis. The Supreme Court upheld the Indian patent office's rejection of the ...